Laurus Labs Limited Share Price and Company Fundamentals
Last traded: Today at 9:42 AM
Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. Further, it develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceutical field. The company was incorporated in 2005 and is based in Hyderabad, India.
Key Metrics
PE ratio
30.53
PB ratio
7.51
Dividend yield
0.43%
Beta
1.44
Market cap
-
Enterprise value
-
Company profile
| Industry / Sector | Drug Manufacturers—Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 5304 |
| Website | https://www.lauruslabs.com |
| Mailing address | Serene Chambers 2nd Floor Road No. 7 Banjara Hills Hyderabad 500034 India |
| Phone / Fax | 91 40 3980 4333 / 91 40 3980 4320 |
Dividends
Dividend yield
0.43%
Dividend amount
₹2.00
Payout ratio
10.42%
5Y Avg. yield
0.36%
Laurus Labs Limited paid ₹2.00 dividend and the ex-dividend date was 10 May 2022.The dividend payout ratio is 10.42%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.LAURUSLABS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
LAURUSLABS's forward dividend amount is ₹4.8 and the forward dividend yield is 1.03%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
Company Executives
As of Jul 2022, following are the company executives and directors listed on Laurus Labs Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Satyanarayana Chava M.Sc., Ph.D. | CEO & Whole Time Director | 60 | 275.24M |
| Mr. Vantaram Venkata Ravi Kumar F.C.M.A., DIS, Dip in Mgmt. | CFO & Whole-Time Director | 56 | 62.42M |
| Mr. Srinivasa Rao Suryadevara M.Sc., B.Sc | Sr. VP of Manufacturing | 58 | |
| Mr. Chagarlamudi Sita Ramaiah | Sr. VP of Fin. | 48 | |
| Mr. Dammalapati Venkata Lakshmi Narasimha Rao | Sr. VP of Synthesis | 52 | |
| Mr. Krishna Chaitanya Chava | Exec. VP and Head of Synthesis & Ingredients | 31 | |
| Mr. Rajaram Iyer M.B.A. | Sr. VP of Portfolio Management | 47 | |
| Mr. Vivek Kumar | Sr. Gen. Mang. of Investor Relations | ||
| Mr. Gogireddy Venkateswar Reddy | Asst. VP of Legal & Secretarial, Compliance Officer & Company Sec. | ||
| Mr. Narasimha Rao Chava | Sr. VP of HR | 53 |
Profitability and management effectiveness
Profit margin
16.77%
Operating margin
23.81%
Return on assets
11.55%
Return on equity
27.93%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Laurus Labs Limited is and its enterprise value is .
The LAURUSLABS's stocks Beta value is 1.44 making it 44% more volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Laurus Labs Limited (NSE:LAURUSLABS) Frequently Asked Questions
1. What is Laurus Labs Limited's Stock Symbol?
Laurus Labs Limited trades on NSE under the ticker symbol "LAURUSLABS".
2. What is Laurus Labs Limited's stock price today?
One share of LAURUSLABS stock can currently be purchased for approximately ₹462.95.
3. How can I contact Laurus Labs Limited?
Laurus Labs Limited's mailing address is Serene Chambers 2nd Floor Road No. 7 Banjara Hills Hyderabad 500034 India. The company can be reached via phone at 91 40 3980 4333.
4. What is Laurus Labs Limited's official website?
The official website of Laurus Labs Limited is https://www.lauruslabs.com.